Cargando…
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma
OBJECTIVE: Genomic biomarkers predicting immune checkpoint inhibitor (ICI) treatment outcomes for Asian metastatic melanoma have been rarely reported. This study presents data on next‐generation sequencing (NGS) and tumour microenvironment biomarkers in 33 cases. METHODS: Thirty‐three patients with...
Autores principales: | Chang, John Wen‐Cheng, Huang, Chien‐Jung, Huang, Wen‐Kuan, Wang, Yu‐Chao, Hsieh, Jia‐Juan, Chang, Yao‐Yu, Huang, Yen‐Lin, Wu, Chia‐Ling, Wang, Yeh‐Han, Chen, Shu‐Jen, Tan, Kien Thiam, Chen, Chiao‐Ping, Wu, Chiao‐En |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463562/ https://www.ncbi.nlm.nih.gov/pubmed/37649975 http://dx.doi.org/10.1002/cti2.1465 |
Ejemplares similares
-
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
por: Wu, Chiao-En, et al.
Publicado: (2020) -
Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
por: Wu, Chiao-En, et al.
Publicado: (2020) -
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020) -
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
por: Pan, Yi-Ru, et al.
Publicado: (2020) -
Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma
por: Pan, Yi-Ru, et al.
Publicado: (2022)